• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Bitcoin's Market Dominance Reaches New Heights

user avatar

by Giorgi Kostiuk

a year ago


Bitcoin's market share is approaching 60%, raising speculations about the future of the altcoin sector, says Vivien Lin.

Bitcoin Leads in Market Capitalization

Vivien Lin notes that Bitcoin's supremacy signifies a resilient move toward the top asset. During market uncertainty, many see it as a 'safe haven.' This could lead to mixed implications for other digital assets, particularly altcoins. Bitcoin's market share has reached approximately 58.6%, linked to macroeconomic factors like anticipated Fed policy changes and potential interest rate cuts. These events have heightened Bitcoin's demand as a stable asset, especially during uncertain periods, pushing its price near the $75,000 psychological threshold. For many investors, Bitcoin's stability amidst volatility makes it a dependable choice.

Analysts point out that Bitcoin’s present price level strengthens its status as 'digital gold' within the crypto market.None

Capital Flow Shifts from Altcoins to Bitcoin

According to BingX's report, the increase in Bitcoin's market share has resulted in a worrying situation for altcoins. In this context, capital flow is shifting from minor assets. Many altcoins rely on innovative applications to attract investments. However, Bitcoin's dominance can impede this growth, leading to reduced liquidity.

Bitcoin's growing market dominance is creating complex conditions for altcoins while emphasizing its role as a reliable investment tool.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

BioAge Labs Focuses on Metabolic Aging with AI

chest

BioAge Labs is utilizing machine learning to explore metabolic aging and develop treatments for metabolic disorders.

user avatarAyman Ben Youssef

Neumora Therapeutics Targets Brain Diseases with AI

chest

Neumora Therapeutics is developing AI-driven solutions for treating brain diseases, including schizophrenia and Alzheimer's.

user avatarSon Min-ho

Relay Therapeutics Innovates Drug Discovery with AI

chest

Relay Therapeutics is using its AI-powered platform to enhance drug discovery processes in oncology.

user avatarJacob Williams

AI Advances in Biotech: Nobel Prize Winners and Promising Companies

chest

In 2024, the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John Jumper for their groundbreaking work in using machine learning to design entirely new proteins, highlighting the growing role of AI in biotech.

user avatarTando Nkube

OBBBA Law Restores R&D Deductions for Biotech Companies

chest

The One Big Beautiful Bill Act restores 100% deduction of R&D expenses for biotech companies, aimed at revitalizing domestic industries and reducing financial pressure.

user avatarZainab Kamara

Launch of OTCfi Token on Olympus Chain

chest

Launch of OTCfi Token on Olympus Chain as part of the partnership between Metavesco and BLAQclouds, aimed at expanding utility in crypto and OTC markets.

user avatarAisha Farooq

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.